Clinical Trials
53 trialsBio-lung
University Hospital, Lille
Molecular Predictors of Cancer in Patients at High Risk of Lung Cancer
Vanderbilt-Ingram Cancer Center
Circulating Tumor Cells (CTC) in Lung Cancer
Indiana University
COMETH
University of Kansas Medical Center
Immune Signature Analysis of Disease Progression in Post Immunotherapy Lung Cancer Patients
Wake Forest University Health Sciences
Paclitaxel Therapeutic Drug Monitoring in Cancer Patients
Wake Forest University Health Sciences
ELEPHAS-04
Mayo Clinic
DuTOC
Dutch Society of Physicians for Pulmonology and Tuberculosis
A Study of Lung Cancer Screening in People With Unexplained Weight Loss
Memorial Sloan Kettering Cancer Center
Determination and Validation of a Multi-analyte Assay for Lung Cancer Screening
Nucleix Ltd.
A Study to Examine Biomarkers From Lung and Blood Samples in Participants With Suspected Lung Cancer
Janssen Research & Development, LLC
RESISTYR
Rennes University Hospital
Pan-tumor MRD Study
Paradigm Health
PROACT-LUNG
Freenome Holdings Inc.
IPON-3
Maastricht Radiation Oncology
NEO-TAN
University Hospital, Montpellier
Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers
Stanford University
Genetic Susceptibility to Lung Cancer in Never Smokers
Memorial Sloan Kettering Cancer Center
EGFR Lung Canc
Our Lady of the Lake Hospital
FUTURE
Assistance Publique Hopitaux De Marseille
LUTON
Hospices Civils de Lyon
Lung EpiCheck Biomarkers Development Study
Nucleix Ltd.
RICEPS
University Hospital, Tours
Use Peripheral Blood Proteomics to Predict the Treatment Response and Toxicities in NSCLC Immunotherapy
University of Iowa
LUNGDIET
Assistance Publique - Hôpitaux de Paris
MRI and Biomarkers for Lung Nodules Detected During Lung Cancer Screening
Cedars-Sinai Medical Center
CINECI
University Hospital, Tours
PD-RAD
The Christie NHS Foundation Trust
DNA Repair and Genetic Susceptibility to Lung Cancer
Memorial Sloan Kettering Cancer Center
Establishment of a Tumor Bank for Blood Samples
Medical University of Vienna
PROPHETIC
OncoHost Ltd.
'Lung Health Check' Biomarker Study
Royal Marsden NHS Foundation Trust
LUN0017
Stanford University
DECAMP-1
Boston University
ADOPT
University of Dundee
GOLF
Royal Marsden NHS Foundation Trust
A Pilot Study to Develop Predictive Biomarkers for the Response to Immunotherapy in Lung Cancer
Abramson Cancer Center at Penn Medicine
The Establishment and Clinical Application of a Prediction Model of Lung Cancer Distant Metastasis Based on the Genomic Characteristics of Circulating Tumor Cells
Chinese Medical Association
Personalizing Immune Checkpoint Inhibitor Therapy
Holy Cross Hospital, Maryland
BioForte Technology for in Silico Identification of Candidates for a New Microbiome-based Therapeutics and Diagnostics
Ardigen
AImmune - Artificial Intelligence Algorithm for Identification of Immunogenic Neoepitopes of Cancer to Predict and Boost Patient's Response to Immunotherapies.
Ardigen
Sleep Apnea and Lung Cancer
Zagazig University
LUCID
Cambridge University Hospitals NHS Foundation Trust
MechLungCa
Washington University School of Medicine
LEMA
The Netherlands Cancer Institute
Protein and RNA Expression Patterns in Predicting Response to Treatment in Patients With Lung Cancer
Vanderbilt-Ingram Cancer Center
Is There Any Relation Between Serum Anti-p53 Antibody and TLG, MTV and SUV as PET Parameters in Lung Cancer Patients?
Cumhuriyet University
Metabolism of Lipids in Advanced Cancer
AHS Cancer Control Alberta
Thromboelastography During Surgery for Malignant Pleural Mesothelioma
Brigham and Women's Hospital
Usefulness of Blood Biomarkers for Overall Survival in NSCLC
Maastricht Radiation Oncology